Samumed samumed.com


Public list: Unicorns - Billion Dollar Startups (363) Pharma Startups (6570) Cancer Therapeutics (1180) Rare Diseases (230)

Samumed, formerly known as Wintherix & Epitherix, has identified a number of novel drug compounds to selectively activate or inhibit the Wnt pathway toward regenerative medicine and treatment of oncology and degenerative diseases. The company's traditional small molecule drug development approach, combined with its unique ability to control the fate of latent human progenitor stem cells has enabled it to develop a series of breakthrough potential new treatments with high potency and excellent sa...Show all

Samumed, formerly known as Wintherix & Epitherix, has identified a number of novel drug compounds to selectively activate or inhibit the Wnt pathway toward regenerative medicine and treatment of oncology and degenerative diseases. The company's tradi...Show all

Company (Alive / Active)

Phone: 858-926-2900

Fax:

9381 Judicial Drive
Suite 160
San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Samumed $438M Aug 6, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Samumed Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.